Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

Autor: Chalmers, JR, Thomas, KS, Apfelbacher, C, Williams, HC, Prinsen, CA, Spuls, PI, Simpson, E, Gerbens, LAA, Boers, M, Barbarot, S, Stalder, JF, Abuabara, K, Aoki, V, Ardeleanu, M, Armstrong, J, Bang, B, Berents, TL, Burton, T, Butler, L, Chubachi, T, Cresswell-Melville, A, DeLozier, A, Eckert, L, Eichenfield, L, Flohr, C, Futamura, M, Gadkari, A, Gjerde, ES, van Halewijn, KF, Hawkes, C, Howells, L, Howie, L, Humphreys, R, Ishii, HA, Kataoka, Y, Katayama, I, Kouwenhoven, W, Langan, SM, Leshem, YA, Merhand, S, Mina-Osorio, P, Murota, H, Nakahara, T, Nunes, FP, Nygaard, U, Nygårdas, M, Ohya, Y, Ono, E, Rehbinder, E, Rogers, NK, Romeijn, GLE, Schuttelaar, MLA, Sears, AV, Simpson, MA, Singh, JA, Srour, J, Stuart, B, Svensson, Å, Talmo, G, Talmo, H, Teixeira, HD, Thyssen, JP, Todd, G, Torchet, F, Volke, A, von Kobyletzki, L, Weisshaar, E, Wollenberg, A, Zaniboni, M

This is the report from the fifth meeting of the Harmonising Outcome Measures for Eczema initiative (HOME V). The meeting was held on 12-14 June 2017 in Nantes, France, with 81 participants. The main aims of the meeting were (i) to achieve consensus

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::c8c44e6d89d34ae1566e6cfcce58ea90

Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting.

Autor: van Geel N; Department of Dermatology, Ghent University Hospital, Ghent, Belgium., Wolkerstorfer A; Department of Dermatology, Institute for Pigment Disorders and Infection, Immunity Institute Amsterdam UMC, Amsterdam, The Netherlands., Ezzedine K; Department of Dermatology, Henri Mondor Hospital, UPE-Université Paris-Est, Créteil, France., Pandya AG; Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas., Bekkenk M; Department of Dermatology, Institute for Pigment Disorders and Infection, Immunity Institute Amsterdam UMC, Amsterdam, The Netherlands., Grine L; Department of Dermatology, Ghent University Hospital, Ghent, Belgium., Van Belle S; Department of Dermatology, Ghent University Hospital, Ghent, Belgium., Lommerts JE; Department of Dermatology, Institute for Pigment Disorders and Infection, Immunity Institute Amsterdam UMC, Amsterdam, The Netherlands., Hamzavi I; Department of Dermatology, Henry Ford Hospital, Detroit, Michigan., Harris JE; Department of Dermatology, The University of Massachusetts Medical School, Worcester, Massachusetts., Eleftheriadou V; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK., Esmat S; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt., Kang HY; Department of dermatology, Ajou University School of Medicine, Suwon, Korea., Kumarasinghe P; Department of Dermatology, Fiona Stanley Hospital, University of Western Australia, Perth, Western Australia, Australia., Lan CE; Department of Dermatology, Kaohsiung Medical University Hospital and College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan., Parsad D; Department of Dermatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India., Raboobee N; Department of Dermatology, Westville Hospital, Westville, South Africa., Flora Xiang L; Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China., Suzuki T; Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan., Prinsen CA; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, The Netherlands., Taieb A; Department of Dermatology, INSERM U 1035, Bordeaux University Hospitals, University of Bordeaux, Bordeaux, France., Picardo M; San Gallicano Dermatologic Institute, Rome, Italy., Speeckaert R; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.

Publikováno v: Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2019 Sep; Vol. 32 (5), pp. 728-733. Date of Electronic Publication: 2019 May 09.

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Autor: Chalmers JR; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Thomas KS; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Apfelbacher C; Medical Sociology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany., Williams HC; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Prinsen CA; Department of Epidemiology and Biostatistics, EMGO+ Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands., Spuls PI; Department of Dermatology, Academic Medical Center, Amsterdam, the Netherlands., Simpson E; Department of Dermatology, Oregon Health and Science University, Portland, OR, U.S.A., Gerbens LAA; Department of Dermatology, Academic Medical Center, Amsterdam, the Netherlands., Boers M; VU University Medical Center, Amsterdam, the Netherlands., Barbarot S; Department of Dermatology, Nantes University Hospital (CHU de Nantes), France., Stalder JF; Department of Dermatology, Nantes University Hospital (CHU de Nantes), France., Abuabara K; Department of Dermatology, University of California San Francisco, San Francisco, CA, U.S.A., Aoki V; University of São Paulo Medical School, São Paulo, Brazil., Ardeleanu M; Regeneron Pharmaceuticals, Tarrytown, NY, U.S.A., Armstrong J; Galderma, Paris, France., Bang B; LEO Pharma, Ballerup, Denmark., Berents TL; Oslo University Hospital, Oslo, Norway., Burton T; Patient, Nottingham, U.K., Butler L; National Eczema Association, San Rafael, CA, U.S.A., Chubachi T; GlaxoSmithKline, Research Triangle Park, NC, U.S.A., Cresswell-Melville A; Eczema Society of Canada, Keswick, ON, Canada., DeLozier A; Eli Lilly and Company, Indianapolis, IN, U.S.A., Eckert L; Sanofi, Chilly-Mazarin, France., Eichenfield L; Rady Children's Hospital, University of California San Francisco, San Diego, CA, U.S.A., Flohr C; St John's Institute of Dermatology, St Thomas' Hospital, London, U.K., Futamura M; Nagoya Medical Center, Nagoya, Japan., Gadkari A; Regeneron Pharmaceuticals, Tarrytown, NY, U.S.A., Gjerde ES; The Psoriasis and Eczema Association of Norway, Oslo, Norway., van Halewijn KF; Erasmus MC, University Medical Centre, Rotterdam, the Netherlands., Hawkes C; GlaxoSmithKline, Uxbridge, U.K., Howells L; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Howie L; Global Parents for Eczema Research, Brisbane, Australia., Humphreys R; National Eczema Society, London, U.K., Ishii HA; Brazilian Atopic Dermatitis Association (AADA), São Paulo, Brazil., Kataoka Y; Osaka Prefectural Medical Center for Respiratory and Allergic Disease, Osaka, Japan., Katayama I; Osaka University, Osaka, Japan., Kouwenhoven W; Dutch Association for People with Atopic Dermatitis, Nijkerk, the Netherlands., Langan SM; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, U.K., Leshem YA; Beilinson Hospital and Tel Aviv University, Petah Tikva and Tel Aviv, Israel., Merhand S; Association Française de l'Eczéma, Redon, France., Mina-Osorio P; Regeneron Pharmaceuticals, Tarrytown, NY, U.S.A., Murota H; Department of Dermatology, Osaka University, Suita, Japan., Nakahara T; Department of Dermatology, Kyushu University, Fukuoka, Japan., Nunes FP; Eli Lilly and Company, Indianapolis, IN, U.S.A., Nygaard U; Eli Lilly and Company, Indianapolis, IN, U.S.A., Nygårdas M; Sanofi Genzyme, Stockholm, Sweden., Ohya Y; National Centre for Child Health and Development, Tokyo, Japan., Ono E; Osaka University, Osaka, Japan., Rehbinder E; Department of Dermatology, Oslo University Hospital, Oslo, Norway., Rogers NK; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Romeijn GLE; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Schuttelaar MLA; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Sears AV; St John's Institute of Dermatology, St Thomas' Hospital, London, U.K., Simpson MA; Dermavant Sciences, Inc., Durham, NC, U.S.A., Singh JA; Department of Medicine, University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center, Birmingham, AL, U.S.A., Srour J; Klinik und Poliklinik für Dermatologie und Allergologie der LMU - München, Munich, Germany., Stuart B; Primary Care and Population Sciences Division, University of Southampton, Southampton, U.K., Svensson Å; Department of Dermatology and Venereology, Lund University, Malmö, Sweden., Talmo G; The Psoriasis and Eczema Association of Norway, Haugesund, Norway., Talmo H; The Psoriasis and Eczema Association of Norway, Haugesund, Norway., Teixeira HD; AbbVie Inc., North Chicago, IL, U.S.A., Thyssen JP; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Hellerup, Denmark., Todd G; University of Cape Town, Cape Town, South Africa., Torchet F; Association Française de l'Eczéma, Redon, France., Volke A; Department of Dermatology, University of Tartu, Tartu, Estonia., von Kobyletzki L; Department of Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.; Department of Public Health Sciences, Karlstad University, Karlstad, Sweden.; CF Wahlgren, Dermatology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Hospital, Stockholm, Sweden.; Department of Dermatology, Venereology and Allergy University Hospital Schleswig-Holstein, Kiel, Germany., Weisshaar E; Department of Social Medicine, Occupational and Environmental Dermatology, Ruprecht Karls University, Heidelberg, Germany., Wollenberg A; Ludwig-Maximilian University, Munich, Germany., Zaniboni M; University of São Paulo, Campinas, Brazil.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2018 May; Vol. 178 (5), pp. e332-e341. Date of Electronic Publication: 2018 Apr 19.

Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life.

Autor: Finlay AY; Division of Infection and Immunity, Department of Dermatology and Wound Healing, Cardiff University, Cardiff, UK., Salek MS; Department of Pharmacy, Pharmacology and Postgraduate Medicine, School of Life & Medical Sciences, University of Hertfordshire, Hatfield, UK., Abeni D; Clinical Epidemiology Unit, IDI-IRCCS FLMM, Rome, Italy., Tomás-Aragonés L; Department of Psychology, Aragon Health Sciences Institute, University of Zaragoza, Zaragoza, Spain., van Cranenburgh OD; Dutch Skin Foundation, Nieuwegein, The Netherlands.; Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands., Evers AW; Health, Medical, and Neuropsychology unit, Leiden University, Leiden, The Netherlands., Jemec GB; Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.; Health Sciences Faculty, University of Copenhagen, Denmark., Linder D; Oslo Center for Biostatistics and Epidemiology, University of Oslo, Oslo, Norway., Manolache L; Dali Medical, Dermatology, Bucharest, Romania., Marrón SE; Department of Dermatology, Alcañiz Hospital, Aragon Health Sciences Institute, Zaragoza, Spain., Prinsen CA; VU University Medical Center, Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, Amsterdam, The Netherlands., Susitaival P; North Karelia Central Hospital, Joensuu, Finland., Chernyshov PV; Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2017 Mar; Vol. 31 (3), pp. 424-431. Date of Electronic Publication: 2016 Oct 24.

Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.

Autor: Gerbens LA; Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands., Prinsen CA; Department of Epidemiology and Biostatistics, EMGO+ Institute for Health and Care Research, VU University Medical Centre, Amsterdam, The Netherlands., Chalmers JR; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK., Drucker AM; Division of Dermatology, University Health Network, Toronto, ON, Canada.; Department of Dermatology, Brown University, Providence, RI, USA., von Kobyletzki LB; Department of Dermatology, Institution for Clinical Science, Lund University, Malmö, Sweden., Limpens J; Medical Library, Academic Medical Centre, Amsterdam, The Netherlands., Nankervis H; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK., Svensson Å; Department of Dermatology, Institution for Clinical Science, Lund University, Malmö, Sweden., Terwee CB; Department of Epidemiology and Biostatistics, EMGO+ Institute for Health and Care Research, VU University Medical Centre, Amsterdam, The Netherlands., Zhang J; Department of Dermatology, Peking University People's Hospital, Peking, China., Apfelbacher CJ; Medical Sociology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany., Spuls PI; Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Allergy [Allergy] 2017 Jan; Vol. 72 (1), pp. 146-163. Date of Electronic Publication: 2016 Jul 13.